BRIEF-Sanofi shares gain 3.5 pct after insulin setback for Novo

Mon Feb 11, 2013 8:02am GMT

Feb 11 (Reuters) - Sanofi SA : * Shares gain 3.5 percent following setback for Novo nordisk's rival

insulin Tresiba in U.S.

Comments (0)

This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Back to top

Reuters.com

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.